Anteris Technologies (ASX:AVR) said the representatives of the underwriters of its US initial public offering partially exercised the over-allotment option for 78,481 common shares at $6 apiece, less underwriting discounts and commissions of $0.42 per share, according to a Wednesday filing with the Australian bourse.
The representatives are TD Cowen, Barclays, and Cantor. The portion of the over-allotment option that was not exercised lapsed on Jan. 11. Settlement occurred on Jan. 14.
Separately, TD Cowen ceased its market stabilization activities on Jan. 12. During the stabilization period, TD Cowen purchased over 2.1 million common shares for prices ranging from $5.14 to $6 on the Nasdaq market.
Anteris Technologies' shares were up more than 3% in recent Wednesday trade.